← Back to Search

Other

E-cigarette Use for Smokers with Mental Illness

N/A
Recruiting
Led By Haruka Minami, Ph.D.
Research Sponsored by Fordham University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
21 years of age or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,2 weeks, 4 weeks, 8 weeks, 12 weeks
Awards & highlights

Study Summary

This trial will study how effective e-cigarettes are for smokers with psychiatric disorders who are not ready to quit smoking.

Who is the study for?
This trial is for English-speaking adults over 21 with a psychiatric disorder who smoke at least 5 cigarettes daily and have been doing so for over 6 months. Participants should not be currently trying to quit smoking, using quitting aids, or have cognitive impairments that prevent informed consent. They must not be pregnant, breastfeeding, planning pregnancy soon, or have unstable heart or lung conditions.Check my eligibility
What is being tested?
The study tests if smokers with psychiatric disorders can switch from regular cigarettes to e-cigarettes provided by the research team for 8 weeks. The impact on their smoking habits will be monitored at different intervals up to three months after starting.See study design
What are the potential side effects?
While specific side effects are not listed in this summary, e-cigarette use may include throat/mouth irritation, coughing, nausea, headache or increased nicotine dependence. Side effects vary based on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline,2 weeks, 4 weeks, 8 weeks, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,2 weeks, 4 weeks, 8 weeks, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Carbon Monoxide Level
Changes in Nicotine Dependence
Changes in the number of combustible cigarettes smoked per day
+2 more
Secondary outcome measures
Changes in Motivation/Readiness to Quit Smoking
Changes in Withdrawal Symptoms

Trial Design

1Treatment groups
Experimental Treatment
Group I: E-cigaretteExperimental Treatment1 Intervention
All participants will be instructed to switch completely from combustible cigarettes to e-cigarettes for the next 8weeks. They will be assessed at baseline, 2 weeks, 4 weeks, 8 weeks, and 12 weeks.

Find a Location

Who is running the clinical trial?

Montefiore Medical CenterOTHER
441 Previous Clinical Trials
582,146 Total Patients Enrolled
Dartmouth CollegeOTHER
79 Previous Clinical Trials
1,415,520 Total Patients Enrolled
Fordham UniversityLead Sponsor
19 Previous Clinical Trials
4,007 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment
2020. "The Effect of Electronic Cigarette Use on Smoking Behaviors Among Smokers Receiving Outpatient Psychiatric Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04014322.
All > Mental Illness > Smoking
~5 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top